Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription 01.07.2019 1 Am J Surg 1 Ann Oncol 2 Ann Surg Oncol 7 BMC Cancer 2 BMJ 1 Br J Cancer 1 Breast Cancer 1 Breast Cancer (Dove Med Press) 11 Breast Cancer Res Treat 1 Breast J 1 Cancer Lett 2 Cancer Res 2 Clin Breast Cancer 1 Clin Cancer Res 2 Eur J Cancer 1 Histopathology 2 Int J Cancer 3 J Clin Oncol 1 J Natl Cancer Inst 1 J Surg Oncol 1 Mod Pathol 1 Nature 1 NPJ Breast Cancer 1 Oncol Rep 2 PLoS One 1 Proc Natl Acad Sci U S A 2 Radiology 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. RANA S, Naik A, Pillai S, Vetto J, et al
   Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program.
   Am J Surg. 2019 Jun 18. pii: S0002-9610(19)30332.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. CARDOSO F, Kyriakides S, Ohno S, Penault-Llorca F, et al
   Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
   Ann Oncol. 2019 Jun 24. pii: 5522519. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Surg Oncol

3. YUAN Q, Wu G, Xiao SY, Hou J, et al
   Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.
   Ann Surg Oncol. 2019 Jun 25. pii: 10.1245/s10434-019-07569.
   PubMed     Text format     Abstract available
   
   
4. WONG SM, Almana N, Choi J, Hu J, et al
   Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
   Ann Surg Oncol. 2019 Jun 21. pii: 10.1245/s10434-019-07517.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

5. MORAN O, Eisen A, Demsky R, Blackmore K, et al
   Predictors of mammographic density among women with a strong family history of breast cancer.
   BMC Cancer. 2019;19:631.
   PubMed     Text format     Abstract available
   
   
6. KHAN OF, Cusano E, Raissouni S, Pabia M, et al
   Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
   BMC Cancer. 2019;19:150.
   PubMed     Text format     Abstract available
   
   
7. DIHGE L, Ohlsson M, Eden P, Bendahl PO, et al
   Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
   BMC Cancer. 2019;19:610.
   PubMed     Text format     Abstract available
   
   
8. WALLWIENER M, Nabieva N, Feisst M, Fehm T, et al
   Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
   BMC Cancer. 2019;19:611.
   PubMed     Text format     Abstract available
   
   
9. PEREZ EA, de Haas SL, Eiermann W, Barrios CH, et al
   Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine +/- pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
   BMC Cancer. 2019;19:620.
   PubMed     Text format     Abstract available
   
   
10. TAKADA K, Kashiwagi S, Asano Y, Goto W, et al
    Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.
    BMC Cancer. 2019;19:615.
    PubMed     Text format     Abstract available
    
    
11. MAJID S, Ryden L, Manjer J
    Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    BMC Cancer. 2019;19:626.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

12. SCHERNHAMMER ES
    Larks, owls, and breast cancer.
    BMJ. 2019;365:l4267.
    PubMed     Text format    
    
    
13. RICHMOND RC, Anderson EL, Dashti HS, Jones SE, et al
    Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.
    BMJ. 2019;365:l2327.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

14. CAPULLI M, Hristova D, Valbret Z, Carys K, et al
    Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.
    Br J Cancer. 2019 Jun 26. pii: 10.1038/s41416-019-0501.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer

15. ZHAO C, Ling X, Li X, Hou X, et al
    MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Breast Cancer. 2019 Jun 26. pii: 10.1007/s12282-019-00989.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

16. NG'IDA FD, Kotoroi GL, Mwangi R, Mabelele MM, et al
    Knowledge and practices on breast cancer detection and associated challenges among women aged 35 years and above in Tanzania: a case in Morogoro Rural District.
    Breast Cancer (Dove Med Press). 2019;11:191-197.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

17. FORNVIK D, Aaltonen KE, Chen Y, George AM, et al
    Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.
    Breast Cancer Res Treat. 2019 Jun 24. pii: 10.1007/s10549-019-05326.
    PubMed     Text format     Abstract available
    
    
18. MICHEL LL, Sommer L, Gonzalez Silos R, Lorenzo Bermejo J, et al
    Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.
    Breast Cancer Res Treat. 2019 Jun 24. pii: 10.1007/s10549-019-05314.
    PubMed     Text format     Abstract available
    
    
19. NEWELL M, Goruk S, Mazurak V, Postovit L, et al
    Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
    Breast Cancer Res Treat. 2019 Jun 24. pii: 10.1007/s10549-019-05331.
    PubMed     Text format     Abstract available
    
    
20. ANDERSSON Y, Bergkvist L, Frisell J, de Boniface J, et al
    Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer.
    Breast Cancer Res Treat. 2019 Jun 24. pii: 10.1007/s10549-019-05328.
    PubMed     Text format     Abstract available
    
    
21. ESEN E, Aslan M, Sonbahar BC, Kerimoglu RS, et al
    YouTube English videos as a source of information on breast self-examination.
    Breast Cancer Res Treat. 2019;173:629-635.
    PubMed     Text format     Abstract available
    
    
22. LEE K, Kang I, Mack WJ, Mortimer J, et al
    Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study.
    Breast Cancer Res Treat. 2019 Jun 24. pii: 10.1007/s10549-019-05332.
    PubMed     Text format     Abstract available
    
    
23. GRANT CV, Carver CM, Hastings SD, Ramachandran K, et al
    Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.
    Breast Cancer Res Treat. 2019 Jun 22. pii: 10.1007/s10549-019-05324.
    PubMed     Text format     Abstract available
    
    
24. ALTUNDAG K
    HER2+ and triple-negative phenotypes in invasive lobular carcinoma might have different specific biological features.
    Breast Cancer Res Treat. 2019;176:719.
    PubMed     Text format    
    
    
25. HEINEY SP, Parker PD, Felder TM, Adams SA, et al
    A systematic review of interventions to improve adherence to endocrine therapy.
    Breast Cancer Res Treat. 2019;173:499-510.
    PubMed     Text format     Abstract available
    
    
26. SILVER MI, Klein W, Samimi G, Minasian L, et al
    Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study((R)).
    Breast Cancer Res Treat. 2019;173:719-726.
    PubMed     Text format     Abstract available
    
    
27. ZDRAVKOVIC D, Ivanovic N, Crnokrak B
    Microinvasion: could it be sufficient diagnostic criteria for the optimal treatment decision?
    Breast Cancer Res Treat. 2019;176:717.
    PubMed     Text format    
    
    

    
    Breast J

28. BISGIN A, Boga I, Yalav O, Sonmezler O, et al
    BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
    Breast J. 2019 Jun 22. doi: 10.1111/tbj.13400.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

29. WANG HX, Gires O
    Tumor-derived extracellular vesicles in breast cancer: From bench to bedside.
    Cancer Lett. 2019;460:54-64.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

30. ACHARYA S, Yao J, Li P, Zhang C, et al
    Sphingosine-kinase-1 signaling promotes metastasis of triple-negative breast cancer.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3803.
    PubMed     Text format     Abstract available
    
    
31. PELUFFO G, Subedee A, Harper NW, Kingston N, et al
    EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3264.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

32. GOEL S, Pernas S, Tan-Wasielewski Z, Barry WT, et al
    Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30313.
    PubMed     Text format     Abstract available
    
    
33. JHA S, Wyld L, Krishnaswamy PH
    The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(19)30078.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

34. MATIKAS A, Zerdes I, Lovrot J, Richard F, et al
    Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data.
    Clin Cancer Res. 2019 Jun 21. pii: 1078-0432.CCR-19-1131.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

35. CRISCITIELLO C, Curigliano G
    Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?
    Eur J Cancer. 2019;117:1-4.
    PubMed     Text format    
    
    
36. REBOLJ M, Blyuss O, Chia KS, Duffy SW, et al
    Long-term excess risk of breast cancer after a single breast density measurement.
    Eur J Cancer. 2019;117:41-47.
    PubMed     Text format     Abstract available
    
    

    
    Histopathology

37. LI J, Ho WY, Tsang JYS, Ni YB, et al
    Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
    Histopathology. 2019;74:567-577.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

38. PERSON H, Guillemin F, Conroy T, Velten M, et al
    Factors of the evolution of fatigue dimensions in patients with breast cancer during the 2 years after surgery.
    Int J Cancer. 2019 Jun 22. doi: 10.1002/ijc.32527.
    PubMed     Text format     Abstract available
    
    
39. MA F, Guan Y, Yi Z, Chang L, et al
    Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.
    Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32536.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

40. COPUR MS, Jonglertham P, Zusag T
    Should All Patients With a Diagnosis of Breast Cancer Undergo Expanded Panel Testing?
    J Clin Oncol. 2019 Jun 27:JCO1900064. doi: 10.1200/JCO.19.00064.
    PubMed     Text format    
    
    
41. RAJAGOPAL PS, Catenacci DVT, Olopade OI
    The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.
    J Clin Oncol. 2019 Jun 27:JCO1900160. doi: 10.1200/JCO.19.00160.
    PubMed     Text format    
    
    
42. TAYLOR A, Tischkowitz M
    Caveat Emptor: The Perils of Panel Testing in Hereditary Breast Cancer.
    J Clin Oncol. 2019 Jun 27:JCO1900122. doi: 10.1200/JCO.19.00122.
    PubMed     Text format    
    
    

    
    J Natl Cancer Inst

43. SACCARELLI CR, Bitencourt AGV, Morris EA
    Breast cancer screening in high-risk women: is MRI alone enough?
    J Natl Cancer Inst. 2019 Jun 24. pii: 5522375. doi: 10.1093.
    PubMed     Text format    
    
    

    
    J Surg Oncol

44. SENER SF
    Advances in axillary surgery for breast cancer 2019.
    J Surg Oncol. 2019 Jun 25. doi: 10.1002/jso.25591.
    PubMed     Text format     Abstract available
    
    

    
    Mod Pathol

45. LOBO J, Petronilho S, Newell AH, Coach J, et al
    E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients.
    Mod Pathol. 2019 Jun 23. pii: 10.1038/s41379-019-0294.
    PubMed     Text format     Abstract available
    
    

    
    Nature

46. WCULEK SK, Malanchi I
    Author Correction: Neutrophils support lung colonization of metastasis-initiating breast cancer cells.
    Nature. 2019 Jun 21. pii: 10.1038/s41586-019-1328.
    PubMed     Text format     Abstract available
    
    

    
    NPJ Breast Cancer

47. SINN BV, Fu C, Lau R, Litton J, et al
    SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer.
    NPJ Breast Cancer. 2019;5:16.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

48. DING W, Li D, Zhang P, Shi L, et al
    Mutual editing of alternative splicing between breast cancer cells and macrophages.
    Oncol Rep. 2019 Jun 18. doi: 10.3892/or.2019.7200.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

49. JUNG SY, Mancuso N, Papp J, Sobel E, et al
    Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
    PLoS One. 2019;14:e0218917.
    PubMed     Text format     Abstract available
    
    
50. WESSELS DJ, Pradhan N, Park YN, Klepitsch MA, et al
    Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment.
    PLoS One. 2019;14:e0218854.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

51. VOUTOURI C, Kirkpatrick ND, Chung E, Mpekris F, et al
    Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies.
    Proc Natl Acad Sci U S A. 2019;116:2662-2671.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

52. THOMPSON CM, Mallawaarachchi I, Dwivedi DK, Ayyappan AP, et al
    The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
    Radiology. 2019 Jun 25:182441. doi: 10.1148/radiol.2019182441.
    PubMed     Text format     Abstract available
    
    
53. MANN RM, Pinker K
    Is Background Parenchymal Enhancement an Important Risk Factor for Breast Cancer Development in Women with Increased Risk?
    Radiology. 2019 Jun 25:191164. doi: 10.1148/radiol.2019191164.
    PubMed     Text format    
    
    

    
    Semin Oncol

54. THOMAS M, Kelly ED, Abraham J, Kruse M, et al
    Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
    Semin Oncol. 2019 Jun 17. pii: S0093-7754(19)30044.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: